Suppliers / Unión Químico Farmacéutica

Unión Químico Farmacéutica

Spain Updated 9 July 2026

Unión Químico Farmacéutica is an API manufacturer based in Spain. It holds 22 active US drug master files across a filed portfolio of 22 molecules. Its GMP standing is certified by EMA and AEMPS (ES). Its most recent recorded inspection, by US FDA, closed on 7 July 2022 as VAI.

22
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
2
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 7 July 2022 VAI US FDA
  • 1 March 2019 VAI US FDA
  • 15 May 2015 NAI US FDA
  • 18 June 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Spain, Spain 3002808431
Barcelona, Spain Not on file
Sant Celoni, Spain Not on file

What they file, and where

Molecule Regulators Docs
Allopurinol US FDA 2
Esomeprazole SFDA (Saudi Arabia), US FDA 2
Mivacurium US FDA 2
Omeprazole SFDA (Saudi Arabia), US FDA 2
Quetiapine SFDA (Saudi Arabia), US FDA 2
Sitagliptin US FDA 2
Acyclovir US FDA 1
Bicalutamide US FDA 1
Cimetidine US FDA 1
Clindamycin US FDA 1
Show all 22 molecules on file
Doxylamine US FDA 1
Emtricitabine SFDA (Saudi Arabia) 1
Famotidine US FDA 1
Ketoconazole US FDA 1
Lansoprazole US FDA 1
Memantine SFDA (Saudi Arabia) 1
Nimodipine US FDA 1
Pantoprazole SFDA (Saudi Arabia) 1
Ranitidine US FDA 1
Ranolazine US FDA 1
Solifenacin Succinate US FDA 1
Tropicamide US FDA 1

Also appears on these molecule pages

Show 5 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
INFARMED (PT) 2 None
EMA None 1
AEMPS (ES) None 1

Comparing suppliers?

Choose your molecules and target markets. Unión Químico Farmacéutica comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.
  • The most recent inspection outcome was VAI, on 7 July 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates